Evidence map›Paper›PMID 38525555›Full record

ArticleCardiovascular research2024

Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans.

Teresa Padro, Victoria Santisteban, Pol Huedo, Montserrat Puntes, Meritxell Aguiló, Jordi Espadaler-Mazo, Lina Badimon

Open access · hybridAbstract read
In one paragraph

Article in Cardiovascular research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Biomedicines · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Safety Assessment ofMicroorganisms · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Teresa PadroCardiovascular Program-ICCC, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Antoni Mª Claret 167, Barcelona 08025, Spain.ORCID 0000-0003-1921-954X
Victoria SantistebanCardiovascular Program-ICCC, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Antoni Mª Claret 167, Barcelona 08025, Spain.ORCID 0000-0003-0623-031X
Pol HuedoR&D Department, AB-Biotics S.A. (Part of Kaneka Corporation), Barcelona, Spain.ORCID 0000-0002-2933-0586
Montserrat PuntesMedicament Research Center (CIM), Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain.
Meritxell AguilóR&D Department, AB-Biotics S.A. (Part of Kaneka Corporation), Barcelona, Spain.ORCID 0000-0001-5367-8737
Jordi Espadaler-MazoR&D Department, AB-Biotics S.A. (Part of Kaneka Corporation), Barcelona, Spain.ORCID 0000-0002-0128-8363
Lina BadimonCardiovascular Program-ICCC, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Antoni Mª Claret 167, Barcelona 08025, Spain.ORCID 0000-0002-9162-2459
AB-Biotics (Spain) · ESHospital de Sant Pau · ESInstituto de Salud Carlos III · ESUniversitat Autònoma de Barcelona · ESUniversitat Internacional de Catalunya · ES

Funding

AB-Biotics SAInstitute of Health Carlos III FIS PI19/01687Spanish Ministry of Economy and Competitiveness of Science 'Agencia Estatal de Investigación AEI/10.13039/501100011033
6 · The paper itself

Abstract

aimsProbiotics with high bile salt hydrolase (BSH) activity have shown to promote cardiovascular health. However, their mechanism(s) of action remain poorly understood. Here, we performed a pilot exploratory study to investigate effects of a 4-week intervention with escalating doses of a BSH-active formula containing Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 on bile acid (BA), lipid profile, and lipoprotein function. METHODS AND

resultsHealthy overweight individuals were included in this study. The probiotic intake was associated with a progressive decrease of conjugated BAs in serum, due to the reduction of tauro- and glyco-conjugated forms. Plasma levels of fibroblast growth factor-19 were significantly reduced and correlated with BA changes. The probiotic induced significant changes in serum lipids, with reduction in non-HDL cholesterol (non-HDLc) and LDL cholesterol (LDLc) levels. The largest decrease was evidenced in the subgroup with higher baseline LDLc levels (LDLc > 130 mg/dL). Fasting levels of circulating apolipoprotein(Apo) B100 and ApoB48 were significantly reduced. Importantly, the decrease in non-HDLc levels was associated with a significant reduction in small LDL particles. Functional testing indicated that LDL particles had a significantly lower susceptibility to oxidation, while HDL particles gained antioxidant capacity after the probiotic intake. The microbiota profile in faeces collected at the end of the study was enriched with members of class Desulfovibrio, a taurine-consuming bacteria, likely because of the increase in free taurine in the gut due to the BSH activity of the probiotic.

conclusionThe intervention with L. plantarum strains induces beneficial effects on BA signature and lipoprotein profile. It reduces ApoB and small LDL levels and LDL susceptibility to oxidation and increases HDL antioxidant capacity. These metabolic profile changes suggest increased protection against atherosclerotic disease.

Indexed as

Bile Acids and SaltsProbioticsAdultAmidohydrolasesApolipoprotein B-100Apolipoprotein B-48BiomarkersCholesterolCholesterol, LDLFemaleFibroblast Growth FactorsGastrointestinal MicrobiomeHumansLactiplantibacillus plantarumMaleMiddle AgedAmidohydrolasesApolipoprotein B-100Apolipoprotein B-48Bile Acids and SaltsBiomarkersCholesterolCholesterol, LDLcholoylglycine hydrolaseFGF19 protein, humanFibroblast Growth FactorsApoBBile acid deconjugationLDL oxidative capacityMicrobiotaSmall LDL

Identifiers

PMID38525555
PMCPMC11135648
OpenAlexW4393158089

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.